Previously, the pharmacological inhibition of GPR4 was reported to remediate myocardial infarction [18], and the genetic deletion of GPR4 improved cardiac function by lowering blood pressure [19] and inhibited apoptosis, which reduced renal ischemia reperfusion injury [20] and intestinal inflammation [21]. The gene discussed is GPR4; the disease is myocardial infarction.